sponsored
PatientsVille.com Logo

PatientsVille

Tikosyn and Pradaxa

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectTikosynPradaxa
GASTROINTESTINAL HAEMORRHAGE0.6% 8.7%
ATRIAL FIBRILLATION6.7% 1.7%
DRUG INEFFECTIVE5.4% 1%
DIZZINESS3.7% 1.9%
CEREBROVASCULAR ACCIDENT0.9% 3.7%
DYSPNOEA3.3% 1.9%
HAEMORRHAGE0.4% 3.1%
FATIGUE3% 1.4%
FALL1.1% 2.8%
ANAEMIA0.5% 2.7%
ELECTROCARDIOGRAM QT PROLONGED2.6% 0%
HEADACHE2.5% 1.4%
DEATH2.2% 1.9%
RECTAL HAEMORRHAGE0% 2.1%
MALAISE2% 0.8%
ISCHAEMIC STROKE0% 1.9%
HEART RATE INCREASED1.9% 0%
DRUG INTERACTION1.8% 0.7%
ASTHENIA1.7% 1.6%
DIARRHOEA1.7% 1.5%
DYSPEPSIA0.4% 1.7%
NAUSEA1.6% 1.4%
HAEMORRHAGIC ANAEMIA0% 1.6%
ARRHYTHMIA1.6% 0%
CHEST PAIN1.5% 0.9%
CARDIAC DISORDER1.4% 0%
CONDITION AGGRAVATED1.4% 0%
EPISTAXIS0.4% 1.3%
FEELING ABNORMAL1.3% 0.4%
CONTUSION0% 1.3%
CEREBRAL HAEMORRHAGE0% 1.3%
COAGULOPATHY0% 1.3%
PALPITATIONS1.3% 0%
COUGH1.2% 0.6%
OFF LABEL USE0.5% 1.2%
LOWER GASTROINTESTINAL HAEMORRHAGE0% 1.2%
UPPER GASTROINTESTINAL HAEMORRHAGE0% 1.2%
RENAL FAILURE ACUTE0% 1.2%
HAEMATURIA0% 1.2%
PNEUMONIA1.1% 1.1%
PAIN1.1% 0.6%
INSOMNIA1.1% 0.4%
HAEMORRHAGE INTRACRANIAL0% 1.1%
MELAENA0% 1.1%
URINARY TRACT INFECTION1% 0.6%
ABDOMINAL DISCOMFORT0.5% 1%
RENAL FAILURE0.4% 1%
PULMONARY EMBOLISM0% 1%
NASOPHARYNGITIS1% 0%
HEART RATE IRREGULAR1% 0%
VENTRICULAR TACHYCARDIA1% 0%
ARTHRALGIA0.8% 0.9%
PAIN IN EXTREMITY0.9% 0.8%
HYPOTENSION0.7% 0.9%
MYOCARDIAL INFARCTION0.7% 0.9%
CARDIAC FAILURE CONGESTIVE0.9% 0.7%
RASH0.9% 0.6%
WEIGHT DECREASED0.9% 0.5%
ABDOMINAL PAIN UPPER0.4% 0.9%
HYPERTENSION0.9% 0.4%
TORSADE DE POINTES0.9% 0%
DEEP VEIN THROMBOSIS0% 0.9%
HAEMOGLOBIN DECREASED0% 0.9%
TRANSIENT ISCHAEMIC ATTACK0% 0.9%
BLOOD PRESSURE INCREASED0.9% 0%
WEIGHT INCREASED0.9% 0%
HAEMATOCHEZIA0% 0.9%
INTERNATIONAL NORMALISED RATIO INCREASED0% 0.9%
OEDEMA PERIPHERAL0.7% 0.8%
PRURITUS0.8% 0.6%
BACK PAIN0.8% 0.6%
VOMITING0.6% 0.8%
GAIT DISTURBANCE0.8% 0.4%
CARDIAC ARREST0.8% 0.4%
HEART RATE DECREASED0.8% 0%
DRUG HYPERSENSITIVITY0.8% 0%
SUBDURAL HAEMATOMA0% 0.8%
MUSCLE SPASMS0.8% 0%
CHEST DISCOMFORT0.7% 0.4%
ANXIETY0.7% 0%
HAEMATOMA0% 0.7%
ABDOMINAL PAIN0% 0.7%
ACUTE KIDNEY INJURY0% 0.7%
DYSPHAGIA0.5% 0.6%
DECREASED APPETITE0.6% 0.5%
CONSTIPATION0.6% 0.5%
CARDIAC FAILURE0.5% 0.6%
LOSS OF CONSCIOUSNESS0.6% 0.4%
CEREBRAL INFARCTION0% 0.6%
HAEMOPTYSIS0% 0.6%
TACHYCARDIA0.6% 0%
BLOOD POTASSIUM DECREASED0.6% 0%
ATRIAL FLUTTER0.6% 0%
DRUG DOSE OMISSION0.6% 0%
RENAL IMPAIRMENT0% 0.6%
THROMBOSIS0% 0.6%
BRONCHITIS0.6% 0%
SEPSIS0% 0.6%
HYPERHIDROSIS0.6% 0%
SYNCOPE0.5% 0.5%
SHOCK HAEMORRHAGIC0% 0.5%
CONFUSIONAL STATE0% 0.5%
HAEMORRHAGIC STROKE0% 0.5%
BLOOD URINE PRESENT0% 0.5%
FLATULENCE0% 0.5%
HAEMATEMESIS0% 0.5%
RESPIRATORY FAILURE0% 0.5%
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED0% 0.5%
BLOOD GLUCOSE INCREASED0.5% 0%
BLOOD PRESSURE DECREASED0.5% 0%
HYPOAESTHESIA0.5% 0%
DEPRESSION0.5% 0%
CHRONIC OBSTRUCTIVE PULMONARY DISEASE0.5% 0%
INFLUENZA0.5% 0%
DRUG EFFECT INCOMPLETE0.5% 0%
SINUSITIS0.5% 0%
TREMOR0.5% 0%
SOMNOLENCE0.5% 0%
PYREXIA0.4% 0.4%
ALOPECIA0.4% 0.4%
FAECES DISCOLOURED0% 0.4%
EMBOLIC STROKE0% 0.4%
GASTROOESOPHAGEAL REFLUX DISEASE0% 0.4%
HEAD INJURY0% 0.4%
JOINT SWELLING0% 0.4%
THROMBOCYTOPENIA0% 0.4%
ACUTE MYOCARDIAL INFARCTION0% 0.4%
HEMIPARESIS0% 0.4%
SUBARACHNOID HAEMORRHAGE0% 0.4%
INTERNAL HAEMORRHAGE0% 0.4%
HYPERSENSITIVITY0.4% 0%
BLOOD CREATININE INCREASED0.4% 0%
MEMORY IMPAIRMENT0.4% 0%
UNEVALUABLE EVENT0.4% 0%
VENTRICULAR FIBRILLATION0.4% 0%
VISUAL IMPAIRMENT0.4% 0%
FLUID RETENTION0.4% 0%
MYALGIA0.4% 0%
OROPHARYNGEAL PAIN0.4% 0%
BRADYCARDIA0.4% 0%
DEHYDRATION0.4% 0%
INFECTION0.4% 0%
PARAESTHESIA0.4% 0%
VENTRICULAR EXTRASYSTOLES0.4% 0%
VISION BLURRED0.4% 0%
APHASIA0% 0.3%
OVERDOSE0% 0.3%

New treatments are found every day. View current Tikosyn research studies and Pradaxa clinical trials

1